Developer of an artificial intelligence-enabled platform designed to advance synthetic lethal oncology. The company's platform identifies novel synthetic lethal targets and biomarkers and develops small-molecule therapeutic drug candidates, enabling clients to discover and develop treatments for cancer.
Developer of an artificial intelligence-based healthcare technology designed to assist clinicians in detecting and diagnosing cancer. The company's technology develops imaging and multi-omics biomarkers and reporting tools using artificial intelligence and MRI, to support cancer screening and diagnosis, enabling clinicians and physicians to make cancer detection accurate, accessible, cost-effective, and quick.
Developer of clinical data tools designed for lifesaving diagnosis and therapies for skin diseases. The company's tool deploys computer vision and artificial intelligence technology with image recognition and artificial intelligence-driven recommendations for the diagnosis of pathologies and offers affordable health assistance to achieve efficient clinical decisions, enabling dermatologists to improve diagnosis, score severity, monitor the evolution of wounds, chronic and malignant skin lesions.